I don't know you guys noticed it or not, Mnkd stock always has a style different from others. If you look at the previous pattern of trials. Mannkind always reached 52 week high even before the release of the data (Close to $10). After the release of the data it went down and then again went up and reached 52 weeks high before the FDA and adcom. After analyzing the pattern I am expecting to have a 52 week high and about $10 by the time they have the cc on Aug5. The data may be released after 2 weeks, I am sure by 1st week of August this will cross $10 atleast once. Any thoughts?
Some of you may already know Pioglitazone already banned in France and India, so they don;t have a real alternative. I would think the entire world is looking for Afrezza. Because of the huge demand I would even think this time the trial data the PPS can be even close to $12
My personal thoughts for you thendy_patty, you will no doubt need to educate yourself more on Al Mann and Afrezza. We will be in the 16-17.00 range before trials or on news release and then we go up from there. Try going long instead of being a closet bash tool that pretends to actually own MNKD shares. At least I'm an honest short doosh and have lost my #$%$.
I am a long investor of MNKD, your pattern seems to be correct as far as PPS and the 1st 2 trials. But this time I believe after the data also the uptrend will continue until the approval. The reason for the uptrend this time because of the 3rd trial, there is a great chance this time approval. So I would think it will be slightly different than the previous 2 trials.